158 related articles for article (PubMed ID: 34213601)
1. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA
Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601
[TBL] [Abstract][Full Text] [Related]
2. Bladder neck and urethral erosions after Macroplastique injections.
Rodríguez D; Jaffer A; Hilmy M; Zimmern P
Low Urin Tract Symptoms; 2021 Jan; 13(1):93-97. PubMed ID: 32783393
[TBL] [Abstract][Full Text] [Related]
3. Does the Polydimethylsiloxane Urethral Injection (Macroplastique
Serati M; Braga A; Scancarello C; De Rosa A; Frigerio M; Baruch Y; Torella M; Salvatore S; Ruffolo AF
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984580
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
[TBL] [Abstract][Full Text] [Related]
5. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
Bano F; Barrington JW; Dyer R
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
[TBL] [Abstract][Full Text] [Related]
6. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review.
Hoe V; Haller B; Yao HH; O'Connell HE
Neurourol Urodyn; 2021 Aug; 40(6):1349-1388. PubMed ID: 34015151
[TBL] [Abstract][Full Text] [Related]
7. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
[TBL] [Abstract][Full Text] [Related]
8. Suburethral mass formation after injection of polydimethylsiloxane (Macroplastique®) urethral bulking agent.
Wasenda EJ; Nager CW
Int Urogynecol J; 2016 Dec; 27(12):1935-1936. PubMed ID: 27530519
[No Abstract] [Full Text] [Related]
9. Can Urethral Bulking Agents Salvage Failed Slings?
Dray EV; Hall M; Covalschi D; Cameron AP
Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
[TBL] [Abstract][Full Text] [Related]
10. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
Siddiqui ZA; Abboudi H; Crawford R; Shah S
Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
[TBL] [Abstract][Full Text] [Related]
11. The role of macroplastique implantation in the management of occult urinary stress incontinence.
Montera R; Scaletta G; Plotti F; Lopez S; Luvero D; Capriglione S; Aloisi A; Gatti A; De Cicco Nardone C; Carassiti R; Terranova C; Angioli R
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():124-128. PubMed ID: 29704816
[TBL] [Abstract][Full Text] [Related]
12. Durability of Macroplastique volume and configuration in women with stress urinary incontinence secondary to intrinsic sphincter deficiency: A retrospective review.
Carroll TF; Christie A; Foreman M; Kuprasertkul A; Khatri G; Zimmern PE
Low Urin Tract Symptoms; 2021 Jul; 13(3):335-340. PubMed ID: 33354906
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal.
Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE
Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306
[TBL] [Abstract][Full Text] [Related]
14. Can urethral re-bulking improve the outcomes of a prior urethral bulking?
Giammò A; Ammirati E; Geretto P; Manassero A; Squintone L; Falcone M; Del Popolo G; Pistolesi D; Risi O; Costantini E; Giannantoni A; Mancini V; Li Marzi V; Agrò EF; Pastorello M; Musco S; Gontero P
Ther Adv Urol; 2022; 14():17562872211069265. PubMed ID: 35069806
[TBL] [Abstract][Full Text] [Related]
15. The use of urethral bulking injections in post-prostatectomy stress urinary incontinence: A narrative review of the literature.
Nguyen L; Leung LY; Walker R; Nitkunan T; Sharma D; Seth J
Neurourol Urodyn; 2019 Nov; 38(8):2060-2069. PubMed ID: 31432568
[TBL] [Abstract][Full Text] [Related]
16. Urethral bulking agent found in a urethral caruncle which did not respond to topical oestrogens: A case report.
Savvas C; Araklitis G; Shah C; Robinson D; Cardozo L
Case Rep Womens Health; 2020 Oct; 28():e00268. PubMed ID: 33163369
[TBL] [Abstract][Full Text] [Related]
17. A multicenter retrospective cohort study comparing urethral diverticulectomy with and without pubovaginal sling.
Bradley SE; Leach DA; Panza J; Sassani J; Escobar C; Ogorek J; Jackson E; Hudson P; Hamner JJ; Smith PE; Schroeder M; Zeymo A; Wyman AM; Gutman RE
Am J Obstet Gynecol; 2020 Aug; 223(2):273.e1-273.e9. PubMed ID: 32504566
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.
Hegde A; Smith AL; Aguilar VC; Davila GW
Int Urogynecol J; 2013 Jul; 24(7):1151-9. PubMed ID: 23229417
[TBL] [Abstract][Full Text] [Related]
19. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis.
Braga A; Caccia G; Papadia A; Treglia G; Castronovo F; Salvatore S; Torella M; Ghezzi F; Serati M
Maturitas; 2022 Sep; 163():28-37. PubMed ID: 35679770
[TBL] [Abstract][Full Text] [Related]
20. Bulking for stress urinary incontinence in men: A systematic review.
Toia B; Gresty H; Pakzad M; Hamid R; Ockrim J; Greenwell T
Neurourol Urodyn; 2019 Sep; 38(7):1804-1811. PubMed ID: 31321804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
